| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703784 | L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride | 0.0217366743178497 | 0.05163403 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0217366743178497 | 0.29712625 |
| NSC 726578 | Null | 0.0217366743178497 | 0.27528428 |
| NSC 727113 | Null | 0.0217366743178497 | 0.38758872 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0217366743178497 | 0.046232877 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0217366743178497 | 0.20040632 |
| NSC 744688 | Null | 0.0217366743178497 | 0.039439053 |
| NSC 750873 | 2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol | 0.0217366743178497 | 0.19859807 |
| NSC 751605 | (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide | 0.0217366743178497 | 0.13403294 |
| NSC 753427 | 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol | 0.0217366743178497 | 0.15181583 |